Enriched by the vast experience, we are engaged in offering a series of LY2835219 intermediates and related product. LY2835219 is a potent and selective inhibitor of CDK4 and CDK6 with IC50 of 2 nM and 10 nM in cell-free assays, respectively and has been shown good response in anti-cancer. LY2835219 intermediates CAS 1231930-33-8 is precise formulation, secure and on sterile level. Our monthly capacity of LY2835219 intermediates 1231930-33-8 range from gram grade to kilogram grade. We are able to transport the intermediates of LY2835219 CAS NO 1231930-33-8 to appointed destination.
Thera. Category: CDK Inhibitor
Cas No.: 1231930-33-8
Synonym: 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole;6-Bromo-4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazole;1H-BenziMidazole, 6-broMo-4-fluoro-2-Methyl-1-(1-Methylethyl)-;1231930-33-8
Molecular Formula:C11H12BrFN2
Molecular Weight:271
Assay: ≥99.%
Packing: Export worthy packing
lMaterial Safety Data Sheet: Available on request
Usage: Bemaciclib(LY2835219) Intermediates
Related Product:
CAS 1180132-17-5, 5-((4-Ethylpiperazin-1-yl)methyl)pyridin-2-amine
CAS 1231930-33-8, 6-Bromo-4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazole